Hemoglobin-vesicles for a Transfusion Alternative and Targeted Oxygen Delivery

References

• Abe H., Fujihara M., Azuma H., Ikeda H., Ikebuchi K., Takeoka S., Tsuchida E., Harashima H. Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: Effects on coagulation, kallikrein-kinin, and complement systems. Artif. Cell Blood Substit. Biotechnol. 2006; 34: 1–10
   PubMed Web of Science ®Google Scholar
• Abe H., Ikebuchi K., Hirayama J., Fujihara M., Takeoka S., Sakai H., Tsuchida E., Ikeda H. Virus inactivation in hemoglobin solution by heat treatment. Artif. Cell Blood Substit. Immobil. Biotechnol. 2001; 29: 381–388
   PubMed Web of Science ®Google Scholar
• Baines A. D., Adamson G., Wojciechowski P., Pliura D., Ho P., Kluger R. Effect of modifying O2 diffusivity and delivery on glomerular and tubular function in hypoxic perfused kidney. Am J Physiol Renal Physiol. 1998; 274: F744–F752
   Web of Science ®Google Scholar
• Baines A. D., Ho P. O2 affinity of cross-linked hemoglobins modifies O2 metabolism in proximal tubules. J Appl Physiol. 1999; 95: 563–570
   Web of Science ®Google Scholar
• Bangham A. D., Horne R. W. Negative staining of phospholipids and their structure modification by surface-active agents as observed in the electron microscope. J Mol Biol. 1964; 8: 660–668
   PubMed Web of Science ®Google Scholar
• Beissinger R. L., Farmer M. C., Gossage J. L. Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up. ASAIO Trans 1986; 32: 58–63
   PubMedGoogle Scholar
• Benesch R. E., Yung S., Suzuki T., Bauer C., Benesch R. Pyridoxal compounds as specific reagents for the alpha and beta N-termini of hemoglobin. Proc. Natl. Acad. Sci. USA 1973; 70: 2595–2599
   PubMed Web of Science ®Google Scholar
• Brandl M., Gregoriadis G. Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: Vesicle characterization and in-vivo behavior. Biochim. Biophys. Acta 1994; 1196: 65–75
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Artificial cells in medicine and biotechnology. Appl. Biochem. Biotechnol. 1984; 10: 5–24
   PubMed Web of Science ®Google Scholar
• Contaldo C., Plock J., Sakai H., Takeoka S., Tsuchida E., Leunig M., Banic A., Erni D. New generation of hemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue. Crit. Care. Med. 2005; 33: 806–812
   PubMed Web of Science ®Google Scholar
• Contaldo C., Schramm S., Wettstein R., Sakai H., Takeoka S., Tsuchida E., Leunig M., Banic A., Erni D. Improved oxygenation in ischemic hamster flap tissue is correlated with increasing hemodilution with Hb vesicles and their O2 affinity. Am. J Physiol. Heart Circ. Physiol. 2003; 285: H1140–H1147
   Web of Science ®Google Scholar
• Djordjevich L., Miller I. F. Lipid encapsulated hemoglobin as a synthetic erythrocyte. Fed. Proc. 1977; 36: 567
   Google Scholar
• Erni D., Sakai H., Tsai A. G., Banic A., Sigurdsson G. H., Intaglietta M. Hemodynamics and oxygen tension in the microcirculation of ischaemic skin flaps after neural blockade and hemodilution. Br. J Plast. Surg. 1999; 52: 565–572
   PubMedGoogle Scholar
• Erni D., Wettstein R., Schramm S., Contaldo C., Sakai H., Takeoka S., Tsuchida E., Leunig M., Banic A. Normovolemic hemodilution with Hb vesicle solution attenuates hypoxia in ischemic hamster flap tissue. Am. J Physiol. Heart Circ. Physiol. 2003; 284: H1702–H1709
   Web of Science ®Google Scholar
• Goda N., Suzuki K., Naito M., Takeoka S., Tsuchida E., Ishimura Y., Tamatani T., Suematsu M. Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin. Invest 1998; 101: 604–612
   PubMed Web of Science ®Google Scholar
• Hayward J. A., Levine D. M., Neufeld L., Simon S. R., Johnston D. S., Chapman D. Polymerized liposomes as stable oxygen-carriers. FEBS Lett 1985; 187: 261–266
   PubMed Web of Science ®Google Scholar
• Hunt C. A., Burnette R. R. Neohemocytes. Prog. Clin. Biol. Res. 1983; 122: 59–69
   PubMedGoogle Scholar
• Izumi Y., Sakai H., Takeoka S., Kose T., Hamada K., Yoshizu A., Horinouchi H., Kato R., Nishide H., Tsuchida E., Kobayashi K. Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model. ASAIO J. 1997; 43: 289–97
   PubMed Web of Science ®Google Scholar
• Kato A., Tanaka I., Arakawa M., Kondo T. Liposome-type artificial red blood cells stabilized with carboxymethyl chitin. Biomater. Med. Devices Artif. Organs 1985; 13: 61–82
   PubMed Web of Science ®Google Scholar
• Kimoto S., Hori M., Toyoda T., Sekiguchi W. Artificial red cells. Gekachiryou (Surgical Therapy) 1968; 19: 324–332, (in Japanese)
   Google Scholar
• Li S., Nickels J., Palmer A. F. Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes. Biomaterials 2005; 26: 3759–3769
   PubMed Web of Science ®Google Scholar
• Linberg R., Conover C. D., Shum K. L., Shorr R. G. Increased tissue oxygenation and enhanced radiation sensitivity of solid tumors in rodents following polyethylene glycol conjugated bovine hemoglobin administration. In Vivo 1988; 12: 167–173
   Google Scholar
• Liu L., Yonetani T. Preparation and characterization of liposome-encapsulated hemoglobin by a freeze-thaw method. J Microencapsul. 1994; 11: 409–421
   PubMed Web of Science ®Google Scholar
• Murray J. A., Ledlow A., Launspach J., Evans D., Loveday M., Conklin J. L. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995; 109: 1241–1248
   PubMed Web of Science ®Google Scholar
• Naito Y., Fukutomi I., Masada Y., Sakai H., Takeoka S., Tsuchida E., Abe H., Hirayama J., Ikebuchi K., Ikeda H. Virus removal from hemoglobin solution using Planova membrane. J Artif. Organs 2002; 5: 141–145
   Google Scholar
• Nakai K., Usuba A., Ohta T., Kuwabara M., Nakazato Y., Motoki R., Takahashi T. A. Coronary vascular bed perfusion with a polyethylene glycol-modified hemoglobin-encapsulated liposome, neo red cell, in rats. Artif. Organs 1998; 22: 320–325
   PubMed Web of Science ®Google Scholar
• Nemoto M., Mito T., Brinigar W. S., Fronticelli C., Koehler R. C. Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse. J Appl. Physiol. 2006; 100: 1688–91
   PubMed Web of Science ®Google Scholar
• Phillips W. T., Klipper R. W., Awasthi V. D., Rudolph A. S., Cliff R., Kwasiborski V., Goins B. A. Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J Pharmacol. Exp. Ther. 1999; 288: 665–670
   PubMed Web of Science ®Google Scholar
• Plock J. A., Contaldo C., Sakai H., Tsuchida E., Leunig M., Banic A., Menger M. D., Erni D. Is hemoglobin in hemoglobin vesicles infused for isovolemic hemodilution necessary to improve oxygenation in critically ischemic hamster skin?. Am. J Physiol. Heart Circ. Physiol. 2005; 289: H2624–H2631
   Web of Science ®Google Scholar
• Plock J. A., Tromp A. E., Contaldo C., Spanholtz T., Sinovcic D., Sakai H., Tsuchida E., Leunig M., Banic A., Erni D. Hemoglobin vesicles reduce hypoxia-related inflammation in critically ischemic hamster flap tissue. Crit. Care Med. 2007; 35: 899–905
   PubMed Web of Science ®Google Scholar
• Rudolph A. S., Klipper R. W., Goins B., Phillips W. T. In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc. Natl. Acad. Sci. USA 1991; 88: 10976–10980
   PubMed Web of Science ®Google Scholar
• Sakai H., Hamada K., Takeoka S., Nishide H., Tsuchida E. Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol. Progress 1996; 12: 119–125
   PubMed Web of Science ®Google Scholar
• Sakai H., Hara H., Yuasa M., Tsai A. G., Takeoka S., Tsuchida E., Intaglietta M. Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension. Am. J Physiol. Heart Circ. Physiol. 2000; 279: H908–H915
   PubMed Web of Science ®Google Scholar
• Sakai H., Horinouchi H., Masada Y., Yamamoto M., Takeoka S., Kobayashi K., Tsuchida E. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit. Care Med. 2004; 32: 539–545
   PubMed Web of Science ®Google Scholar
• Sakai H., Horinouchi H., Yamamoto M., Ikeda E., Takeoka S., Takaori M., Tsuchida E., Kobayashi K. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: Degradation of HbV and erythropoiesis in a rat spleen for 2 weeks. Transfusion 2006; 46: 339–347
   PubMed Web of Science ®Google Scholar
• Sakai H., Sato A., Takeoka S., Tsuchida E. Rheological properties of hemoglobin-vesicles (artificial oxygen carriers) suspended in a series of plasma substitute aqueous solutions. Langmuir 2007; 23: 8121–8128
   PubMed Web of Science ®Google Scholar
• Sakai H., Suzuki Y., Kinoshita M., Takeoka S., Maeda N., Tsuchida E. O2 release from Hb vesicles evaluated using an artificial, narrow O2-permeable tube: Comparison with RBCs and acellular Hbs. Am. J. Physiol. Heart Circ. Physiol. 2003; 285: H2543–H2551
   Web of Science ®Google Scholar
• Sakai H., Takeoka S., Park S., Kose T., Izumi Y., Yoshizu A., Nishide H., Kobayashi K., Tsuchida E. Surface-modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90%-exchange transfusion in anesthetized rats. Bioconjugate Chem. 1997; 8: 23–30
   PubMed Web of Science ®Google Scholar
• Sakai H., Takeoka S., Yokohama H., Seino Y., Nishide H., Tsuchida E. Purification of concentrated Hb using organic solvent and heat treatment. Protein Expression Purif. 1993; 4: 563–569
   PubMed Web of Science ®Google Scholar
• Sakai H., Tomiyama K., Sou K., Takeoka S., Tsuchida E. Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjugate Chem. 2000; 11: 425–32
   PubMed Web of Science ®Google Scholar
• Sakai H., Tsai A. G., Kerger H., Park S., Takeoka S., Nishide H., Tsuchida E., Intaglietta M. Subcutaneous microvascular responses to hemodilution with red cell substitutes consisting of polyethylene glycol-modified vesicles encapsulating hemoglobin. J Biomed. Mater. Res. 1998; 40: 66–78
   PubMed Web of Science ®Google Scholar
• Shirasawa T., Izumizaki M., Suzuki Y., Ishihara A., Shimizu T., Tamaki M., Huang F., Koizumi K., Iwase M., Sakai H., Tsuchida E., Ueshima K., Inoue H., Koseki H., Senda T., Kuriyama T., Homma I. Oxygen affinity of hemoglobin regulates O2 consumption, metabolism, and physical activity. J. Biol. Chem. 2003; 278: 5035–5043
   PubMed Web of Science ®Google Scholar
• Sou K., Endo T., Takeoka S., Tsuchida E. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjugate Chem. 2000; 11: 372–379
   PubMed Web of Science ®Google Scholar
• Sou K., Klipper R., Goins B., Tsuchida E., Phillips W. T. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J. Pharmacol. Exp. Ther. 2005; 312: 702–709
   PubMed Web of Science ®Google Scholar
• Sou K., Naito Y., Endo T., Takeoka S., Tsuchida E. Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol. Progress 2003; 19: 1547–1552
   PubMed Web of Science ®Google Scholar
• Stein J. C., Ellsworth M. L. Capillary oxygen transport during severe hypoxia: role of hemoglobin oxygen affinity. J. Appl. Physiol. 1993; 75: 1601–1607
   PubMed Web of Science ®Google Scholar
• Takeoka S., Ohgushi T., Terase K., Ohmori T., Tsuchida E. Layer-controlled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly. Langmuir 1996; 12: 1755–1759
   Web of Science ®Google Scholar
• Toyoda T. Artificial blood. Kagaku 1695; 35: 7–13, (in Japanese)
   Google Scholar
• Tsai A. G., Vandegriff K. D., Intaglietta M., Winslow R. M. Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics. Am. J. Physiol. Heart Circ. Physiol. 2003; 285: H1411–H1419
   PubMed Web of Science ®Google Scholar
• Usuba A., Motoki R., Miyauchi Y., Suzuki K., Takahashi A. Effect of neo red cells on the canine hemorrhagic shock model. Int. J. Artif. Organs 1991; 14: 739–744
   PubMed Web of Science ®Google Scholar
• Wakamoto S., Fujihara M., Abe H., Sakai H., Takeoka S., Tsuchida E., Ikeda H., Ikebuchi K. Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on agonist-induced platelet aggregation and RANTES release in vitro. Artif. Cell Blood Substit. Immobil. Biotechnol. 2001; 29: 191–201
   PubMed Web of Science ®Google Scholar
• Wakamoto S., Fujihara M., Abe H., Yamaguchi M., Azuma H., Ikeda H., Takeoka S., Tsuchida E. Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. Artif. Cell Blood Substit. Immobil. Biotechnol. 2005; 33: 101–111
   PubMed Web of Science ®Google Scholar
• Wang L., Morizawa K., Tokuyama S., Satoh T., Tsuchida E. Modulation of oxygen-carrying capacity of artificial red cells (ARC). Polymer Adv Technol. 1992; 4: 8–11
   Google Scholar
• Winslow R. M. Targeted O2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artif. Cell Blood Substit. Immobil. Biotechnol. 2005; 33: 1–12
   PubMed Web of Science ®Google Scholar
• Yamazaki M., Aeba R., Yozu R., Kobayashi K. Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats. Circulation 2006; 114(1 Suppl)I220–I225
   Google Scholar
• Yoshioka H. Surface modification of hemoglobin-containing liposomes with poly(ethylene glycol) prevents liposome aggregation in blood plasma. Biomaterials 1991; 12: 861–864
   PubMed Web of Science ®Google Scholar